Nabriva Therapeutics plc Quarterly Common Stock, Shares, Outstanding from Q4 2016 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Nabriva Therapeutics plc quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2016 to Q2 2023.
  • Nabriva Therapeutics plc Common Stock, Shares, Outstanding for the quarter ending June 30, 2023 was 3.23M shares, a 95% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 3.23M -61.3M -95% Jun 30, 2023 10-Q 2023-10-19
Q1 2023 3.2M -58.5M -94.8% Mar 31, 2023 10-Q 2023-05-22
Q4 2022 3.2M +933K +41.1% Dec 31, 2022 10-Q 2023-10-19
Q3 2022 3.02M -51.3M -94.4% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 64.6M +14.8M +29.8% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 61.7M +26.3M +74.3% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 2.27M -18.8M -89.2% Dec 31, 2021 10-K 2023-04-17
Q3 2021 54.3M -95.7M -63.8% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 49.7M -93.2M -65.2% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 35.4M -59.7M -62.8% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 21.1M +11.6M +123% Dec 31, 2020 10-K 2022-03-29
Q3 2020 150M +72M +92.3% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 143M +70.1M +96.1% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 95.1M +23.8M +33.3% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 9.45M -57.6M -85.9% Dec 31, 2019 10-K 2021-03-11
Q3 2019 78M +11.5M +17.3% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 72.9M +31.9M +78% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 71.3M +31.1M +77.3% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 67M +30.3M +82.6% Dec 31, 2018 10-K 2020-03-12
Q3 2018 66.5M Sep 30, 2018 10-Q 2018-11-06
Q2 2018 41M Jun 30, 2018 10-Q 2018-08-09
Q1 2018 40.2M Mar 31, 2018 10-Q 2018-05-08
Q4 2017 36.7M +34M +1250% Dec 31, 2017 10-K 2019-03-12
Q4 2016 2.72M Dec 31, 2016 10-K 2018-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.